Laboratory Equipment · Diagnostic Tests & IVD
Bio-Rad Laboratories: Funding & valuation
Bio-Rad Laboratories returned $295.5M to shareholders in fiscal 2025 and paid $61.6M of income tax.
Data updated Nov 22, 2026 · Back to the company report
Financials
Revenue of $2.6B in 2025. +0.7% on the year before. Net income $759.9M.
$2.6BRevenue2025 · +0.7%
$759.9MNet income2025 · +141.2%
Revenue by yearas filed, with the net income
Sources: SEC
Money
Bio-Rad Laboratories returned $295.5M to shareholders in fiscal 2025 and paid $61.6M of income tax.
$61.6MIncome taxes paidFY2025
$295.5MDividends and buybacksFY2025
$157.6MCapital expenditureFY2025
From its filingssec.gov ↗
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Income taxes paid | $129.6M | $99.4M | $61.6M |
| Shares bought back | $428.7M | $203.6M | $295.5M |
| Capital expenditure | $156.7M | $165.6M | $157.6M |
| Stock-based compensation | $61.3M | $62.3M | $58M |
People cost
Bio-Rad Laboratories filed a median H-1B wage of $141k in 2026.
$74k–$214kH-1B wage range32 positions
Median H-1B wage by role, 2026scale to $214k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".
